[February 12, 2016]

Fertility Market in the US 2016-2020 - Increasing Fertility Issues Among Aging Population - Research and Markets

Research and Markets (http://www.researchandmarkets.com/research/xvm6t8/fertility_market) has announced the addition of the "Fertility Market in the US 2016-2020" report to their offering.

The fertility services market in the US is expected to grow at a CAGR of 4.07% during the period 2016-2020.

Couples with fertility issues are unable to conceive even after regular unprotected coitus (six months if the woman is over age 35). Female or male infertility factors account for one-third of the cases, where a couple is unable to conceive. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors.

Diagnosing the cause of infertility can be difficult but people with fertility issues have many treatment options depending on the underlying problem.

According to the report, the fertility market in the US consists of fertility drugs and assisted reproductive technology (ART) services segments. Increasing fertility issues among the aging population, rising disposable income, growing adoption of fertlity services by homosexual couples, and augmented support from the US federal government are some of the major factors that will impel growth in this market during the forecast period.

The market is divided into the following segments based on treatment type:

• ART
• Infertility drugs

Companies Mentioned:

• Cellcura
• CooperSurgical
• Intramed
• Ferring Pharmaceuticals
• Merck
• Abbott Laboratories
• AbbVie
• Actavis
• Apricus Biosciences
• AstraZeneca
• Auxogyn
• Bristol-Myers Squibb
• Elelixis Diagnostics
• Eli Lilly
• EMD Serono
• IKS International
• In Vitro Care
• Invo Bioscience
• Irvine Scientific
• IVFtech Aps
• Life Global
• Medical Electronic Systems
• Meditex
• Novartis
• Ovascience
• Pantec Biosolutions
• Pfizer
• Sanofi
• Vivus
• Xytex Cryo International.

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Regulatory scenario in the US

PART 06: Market landscape

PART 07: Infertility: An overview

PART 08: Stages of fertility treatment

PART 09: Cost analysis of ART

PART 10: Market segmentation by type

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape

For more information visit http://www.researchandmarkets.com/research/xvm6t8/fertility_market

View source version on businesswire.com: http://www.businesswire.com/news/home/20160212005583/en/

[ Back To TMCnet.com's Homepage ]